Equibles does not estimate personal net worth.
Get an email with a short summary when Intensity Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get INTS alertsLewis H. Bender is recorded as CEO at Intensity Therapeutics, Inc. (INTS). The newest filing on record that lists Lewis H. Bender as CEO at Intensity Therapeutics, Inc. (INTS) is dated April 30, 2026. The proxy statement of Intensity Therapeutics, Inc. reports total compensation of $1,355,482 for Lewis H. Bender in fiscal 2025, including a base salary of $549,150. Disclosed compensation is on record for 4 fiscal years. Lewis H. Bender has spoken on 1 earnings call and 2 other investor events across 1 company, most recently for Intensity Therapeutics, Inc. on September 11, 2026. Intensity Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Intensity Therapeutics, Inc. includes Joseph Talamo (CFO), Daniel Donovan (Board Member), Emer Leahy (Board Member) and 2 others.
“So my first slide is, please be aware there's forward-looking statements and you should read our filings with the SAC.”
“It is my pleasure to provide the latest update of our company's progress in the Invincible 3 and Invincible 4 studies, our business development activities, and our plans for the second half of 2026.”
“Good morning, and welcome to the 2026 Annual Meeting of Stockholders of Intensity Therapeutics, Incorporated. I'm Lou Bender, President, Chief Executive Officer, and Chairman of the Company, and it is my pleasure to welcome all of you.”
Start not stated–present
Last confirmed April 30, 2026
Biotechnology · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Intensity Therapeutics, Inc. (INTS) | President and Chief Executive Officer | $549,150 | $1,355,482 |
| 2024 | Intensity Therapeutics, Inc. (INTS) | President and Chief Executive Officer | $544,121 | $2,486,169 |
| 2023 | Intensity Therapeutics, Inc. (INTS) | President and Chief Executive Officer | $553,173 | $1,235,740 |
| 2022 | Intensity Therapeutics, Inc. (INTS) | President and Chief Executive Officer | $492,827 | $994,571 |
